Market Overview The global radiopharmaceutical theranostics market is experiencing therapeutic isotope innovation where novel alpha and beta emitters with improved therapeutic characteristics are expanding treatment options and patient populations eligible for theranostic approaches. The global radiopharmaceutical theranostics market is projected to exceed USD 12 billion through 2030, with...